About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
A randomized and controlled trial to examine the impact of lingual frenotomy on bottle feeding mechanics
Some babies are born with tongue-tie where an unusually short or tight band of tissue tethers the bottom...